ICD10 code of Von Hippel-Lindau Disease and ICD9 code

Von Hippel-Lindau disease (VHL) is classified under the ICD-10 code Q85.81 (Von Hippel-Lindau syndrome) and the legacy ICD-9 code 759.6 (Other hamartoses, not elsewhere classified). These diagnostic codes are essential for medical billing, clinical documentation, and tracking the multi-system surveillance required for individuals managing this condition.

What is the clinical significance of the Von Hippel-Lindau disease coding?

Because Von Hippel-Lindau disease is a multi-system genetic disorder characterized by the growth of tumors and cysts in various parts of the body, accurate coding is vital for coordinating long-term care. The ICD-10 code Q85.81 allows healthcare providers to flag the diagnosis in electronic health records, ensuring that the patient is flagged for the rigorous, lifelong surveillance protocols required for VHL. Accurate coding facilitates the authorization of complex screenings, such as frequent abdominal MRIs and ophthalmic examinations, which are the standard of care for those with Von Hippel-Lindau disease.

Is Von Hippel-Lindau disease hereditary?

Yes, Von Hippel-Lindau disease is an autosomal dominant genetic condition caused by a mutation in the VHL tumor suppressor gene located on chromosome 3p25.3. Because it is hereditary, approximately 80% of individuals inherit the mutation from an affected parent, while 20% of cases arise from a de novo (new) mutation in the individual. Genetic counseling is strongly recommended for families affected by Von Hippel-Lindau disease to understand the 50% risk of transmission to offspring and the importance of cascade testing for asymptomatic relatives.

What complications are associated with Von Hippel-Lindau disease?

The clinical presentation of Von Hippel-Lindau disease varies significantly, even among family members, but generally involves the development of benign and malignant tumors. The most common manifestations include:

• Hemangioblastomas: Highly vascular tumors found in the central nervous system, particularly the cerebellum, spinal cord, and retina.


• Clear cell renal cell carcinoma (RCC): A malignant kidney cancer that occurs in approximately 70% of individuals with VHL.


• Pheochromocytomas: Adrenal gland tumors that can lead to life-threatening hypertension.


• Pancreatic neuroendocrine tumors (pNETs): Cysts or tumors affecting the pancreas.


• Endolymphatic sac tumors: Often resulting in progressive hearing loss or vestibular dysfunction.

How does the community support those living with Von Hippel-Lindau disease?

Living with a rare, multi-system condition can feel isolating, but you are not alone. Currently, 100 people with Von Hippel-Lindau disease have joined the DiseaseMaps.org community, sharing their experiences with surveillance and treatment pathways. Connecting with others who understand the unique psychological burden of "scanxiety"—the anxiety associated with regular diagnostic imaging—can provide invaluable emotional support. Sharing experiences through platforms like DiseaseMaps.org allows patients to learn about expert-led centers and emerging clinical trials that may not be widely known in general practice.

Next steps

• Consult with a genetic counselor to discuss cascade testing for family members.


• Establish care with a multidisciplinary specialist team (urology, neurosurgery, ophthalmology, and endocrinology) at a VHL center of excellence.


• Join the DiseaseMaps.org community to connect with other patients and caregivers.


• Maintain a personal health record of all imaging results and tumor surveillance dates.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH GARD: Von Hippel-Lindau disease (https://rarediseases.info.nih.gov/diseases/7858/von-hippel-lindau-disease)


• Orphanet: Von Hippel-Lindau disease (https://www.orpha.net/en/disease/detail/892)


• OMIM: VHL gene and syndrome (https://omim.org/entry/193300)


• VHL Alliance: Patient resources and clinical guidelines (https://vhl.org)